In the selected fragments of the RAD50 and MRE11 genes, which have been reported to harbor mutations in cancer, we were unable to confirm the occurrence of the formerly known mutations in our group of either ALL or AML cases. The gene discussed is MRE11; the disease is acute myeloid leukemia.